Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sinovac Biotech

Explore full profile

China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialisation of vaccines

Jing'an District, ChinaFounded 2001Biotech & Life Sciences
Valuation $297M Market cap · Jul/2026
Revenue $386M Latest reported FY
EBITDA $52M Latest reported FY

At a glance

Status
Listed
Founded
2001
Headquarters
Jing'an District, China
Listing
IPO 2003
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
15 countries with
team presence
🇨🇳 China72.7%
🇧🇩 Bangladesh6.7%
🇨🇱 Chile3.4%
🇭🇰 Hong Kong3.1%
🇨🇴 Colombia2.8%
Top 5 of 15 shown
Web traffic by country
18K monthly visits
across markets
🇭🇰 Hong Kong22.2%
🇺🇸 United States21.1%
🇸🇬 Singapore10%
🇮🇳 India8.3%
🇨🇦 Canada6.7%
Top 5 markets shown

Patents

Estimated portfolio value
$10M

192 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Sinovac Biotech was the backer or acquirer, 2021–2024. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Sinovac Biotech's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where Sinovac Biotech deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        Sinovac Biotech's portfolio, mapped.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Sinovac Biotech on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Sinovac Biotech on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles